# InsideTracker

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insidetracker

- Industry: Healthcare IT
- Headquarters: Cambridge, US
- Website: www.insidetracker.com
- Total disclosed funding: $15M
- Latest round: Series B (Sep 8, 2022)
- Investors on record: 4

## About

Based in Massachusetts, US, founded in 2009, Segterra, Inc., doing business as InsideTracker, operates as a health analytics platform. The company was founded by its CSO Gil Blander, Christian Reich, and David Lester. In September 2022, InsideTracker raised USD 15 million in Series B funding led by PeakBridge Cornucopian Capital, OurCrowd, and BASF Venture Capital. As of 2022, the company’s CEO is Rony Sellam.

InsideTracker provides a health span optimization platform, which is a health analyses platform that analyses, collects, and integrates users’ body data including biomarker data from various sources such as blood, DNA, and fitness trackers, to produce recommendations for improving the health span of users. The company’s product line includes InnerAge 2.0, which is an AI-driven personalized health dashboard. In addition, the company offers a mobile application for both Android and iOS users.

The company generates revenue by offering its services on a subscription-based pricing plan. The plans include Ultimate (USD 589), InnerAge 2.0 (USD 249), Blood Results Upload (USD 119), Shalane Flanagan panel (USD 399), home kit (USD 299), DNA Results Upload (USD 29), and A Year of InsideTracker (USD 1,999).

The company plans to use the funds raised in September 2022 to expand operations and its business reach.

## Funding rounds

- Series B, Sep 8, 2022, $15M — BASF, OurCrowd, PeakBridge, Cornucopian Capital

## Investors

- BASF (https://capitalatlas.ai/funds/basf) — Series B
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series B
- PeakBridge (https://capitalatlas.ai/funds/peakbridge) — Series B
- Cornucopian Capital (https://capitalatlas.ai/funds/cornucopian-capital) — Series B